Literature DB >> 6976201

Positive and negative schizophrenia symptoms and the role of dopamine.

T J Crow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6976201     DOI： 10.1192/bjp.139.3.251

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  9 in total

1.  Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis.

Authors:  Tianhao Zhang; Nikolaos Koutsouleris; Eva Meisenzahl; Christos Davatzikos
Journal:  Schizophr Bull       Date:  2014-09-26       Impact factor: 9.306

2.  A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia.

Authors:  Mehdi Farokhnia; Maryam Sabzabadi; Hossein Pourmahmoud; Mohammad-Reza Khodaie-Ardakani; Seyed-Mohammad-Reza Hosseini; Habibeh Yekehtaz; Mina Tabrizi; Farzin Rezaei; Bahman Salehi; Shahin Akhondzadeh
Journal:  Psychopharmacology (Berl)       Date:  2013-09-08       Impact factor: 4.530

3.  Synaptic contacts in schizophrenia: studies using immunocytochemical identification of dopaminergic neurons.

Authors:  N S Kolomeets; N A Uranova
Journal:  Neurosci Behav Physiol       Date:  1999 Mar-Apr

4.  Effects of dopaminergic modulation on automatic semantic priming: a double-blind study.

Authors:  Christina Andreou; Kristina Veith; Vasilis P Bozikas; Tania M Lincoln; Steffen Moritz
Journal:  J Psychiatry Neurosci       Date:  2014-03       Impact factor: 6.186

Review 5.  Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.

Authors:  Robert W Buchanan; Robert Freedman; Daniel C Javitt; Anissa Abi-Dargham; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2007-07-19       Impact factor: 9.306

Review 6.  Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.

Authors:  W Z Potter
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

7.  Abnormalities of localized connectivity in schizophrenia patients and their unaffected relatives: a meta-analysis of resting-state functional magnetic resonance imaging studies.

Authors:  Bo Xiao; Shuai Wang; Jianbo Liu; Tiantian Meng; Yuqiong He; Xuerong Luo
Journal:  Neuropsychiatr Dis Treat       Date:  2017-02-14       Impact factor: 2.570

8.  Correlation of Blood Biochemical Markers with Tardive Dyskinesia in Schizophrenic Patients.

Authors:  Qian Wu; Fengjuan Yuan; Shuo Zhang; Weiting Liu; Qing Miao; Xinhua Zheng; Suxiang Lu; Kaijian Hou
Journal:  Dis Markers       Date:  2022-03-08       Impact factor: 3.434

9.  Substantia nigra/ventral tegmental reward prediction error disruption in psychosis.

Authors:  G K Murray; P R Corlett; L Clark; M Pessiglione; A D Blackwell; G Honey; P B Jones; E T Bullmore; T W Robbins; P C Fletcher
Journal:  Mol Psychiatry       Date:  2007-08-07       Impact factor: 15.992
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.